Calls for papers
-
Avanir Pharmaceuticals has published results from the Phase 3 TARGET study of its AVP-825 intranasal sumatriptan powder compared to placebo for the treatment of migraine. The article appears in the January 2015 issue of Headache.… Read more . . .
-
North Carolina-based Cirrus Pharmaceuticals has announced that it will be investing in a new flexible cGMP suite at its facility in Research Triangle Park, NC and will offer new manufacturing services beginning next year. In… Read more . . .
-
CDMO Irvine Pharmaceutical Services has announced that it will open a new 115,000 sq ft analytical facility in Hangzhou, China, the company said. The Hangzhou location should be fully operational in early 2015. While Irvine’s… Read more . . .
-
Computer aided engineering softwared company CD-adapco has released STAR-CCM+ v9.06, with increased accuracy and faster set-up. The software is useful to inhaler and other device designers for realistic modeling of the behavior of aerosols in… Read more . . .
-
A start-up company called Amiko has launched a campaign on crowd funding site Indiegogo to raise money for manufacturing of its monitoring devices for a variety of dry powder inhalers, the company said. The stated… Read more . . .
-
US-based Monaghan Medical, which sells breath actuated nebulizers manufactured by Trudell Medical International (TMI), is presenting data at CHEST 2014 from a study showing that continuous nebulizers may under-dose medication. According to Monaghan changes in… Read more . . .
-
Copley Scientific has announced a deal with Hyderabad-based Apex Chromatography for the exclusive distribution of Copley inhaler testing products in India and noted that Viraj Sohoni of Apex’s Mumbai office has been appointed as the… Read more . . .
-
Sunovion Pharmaceuticals has announced that all 4 dose levels of its SUN-101 glycopyrrolate inhalation solution tested in a Phase 2 study produced statistically significant improvements in lung function. The 28-day randomized, double-blind, placebo-controlled study involved… Read more . . .
-
Data from Boehringer Ingelheims ANHELTO 1 and ANHELTO 2 studies demonstrate that co-administration of the Spiriva HandiHaler tiotropium DPI and the Striverdi Respimat olodaterol SMI produced significantly greater improvement in the lung function of COPD… Read more . . .
-
Grupo Ferrer Internacional, which markets Alexza Pharmaceuticals’ Adasuve inhaled loxapine in the EU, Latin America, and the CIS countries, will acquire 2 million shares of Alexza common stock at $4 per share, the companies have… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA